Fractyl Health, Inc.
GUTS
$0.66
-$0.01-0.88%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -96.91% | -85.71% | -59.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -96.91% | -85.71% | -59.46% |
| Cost of Revenue | -- | -- | -100.00% | -90.00% | -66.67% |
| Gross Profit | -- | -- | -93.33% | -79.59% | -47.27% |
| SG&A Expenses | 4.15% | -3.56% | -2.72% | -3.45% | 23.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.06% | 3.41% | 21.31% | 39.66% | 60.23% |
| Operating Income | 4.00% | -3.51% | -21.45% | -39.87% | -60.52% |
| Income Before Tax | -21.20% | -105.19% | -94.26% | -79.83% | -30.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.20% | -105.19% | -94.26% | -79.83% | -30.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.20% | -105.19% | -94.26% | -79.83% | -30.12% |
| EBIT | 4.00% | -3.51% | -21.45% | -39.87% | -60.52% |
| EBITDA | 4.25% | -3.05% | -20.86% | -39.20% | -59.69% |
| EPS Basic | 17.18% | -35.51% | 81.34% | 90.37% | 95.09% |
| Normalized Basic EPS | 17.31% | -23.62% | 77.58% | 88.14% | 91.90% |
| EPS Diluted | 17.18% | -35.51% | 81.34% | 90.37% | 95.09% |
| Normalized Diluted EPS | 17.31% | -23.62% | 77.58% | 88.14% | 91.90% |
| Average Basic Shares Outstanding | 113.65% | 74.15% | 65.22% | 137.48% | 436.53% |
| Average Diluted Shares Outstanding | 113.65% | 74.15% | 65.22% | 137.48% | 436.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |